Document Detail

Clinical experience with SonoVue in myocardial perfusion imaging.
MedLine Citation:
PMID:  11058235     Owner:  NLM     Status:  MEDLINE    
Ultrasound-enhancing agents have the potential to evaluate myocardial perfusion, adding a new dimension to echocardiography. This article summarizes the clinical studies involving SonoVue, a new intravenous ultrasound contrast agent, in assessing myocardial perfusion. Safe and well tolerated, SonoVue coupled with echocardiography has the capability to identify perfusion abnormalities, as confirmed by scintigraphic imaging. While the optimal modalities for ultrasound perfusion assessment are not yet determined, numerous technical advances have been introduced: continuous infusion or slow intravenous administration of the agent, harmonic intermittent imaging, pulse inversion, background subtraction, color coding, and others. SonoVue is a promising new agent in the booming field of myocardial contrast echocardiography.
D Rovai; M A Morales; R Amyot; A L'Abbate
Related Documents :
8479935 - 201tl reinjection predicts improvement of left ventricular function following revascula...
8746935 - Functional assessment of ptca results by stress echocardiography: when and how to test.
10423765 - Factors affecting and computation of myocardial perfusion reference images.
24942645 - Effect of temporal acquisition parameters on image quality of strain time constant elas...
16463385 - Quantitative comparison of air, spm, and the fully deformable model for atlas-based seg...
12375825 - A ct image based deterministic approach to dosimetry and radiography simulations.
Publication Detail:
Type:  Case Reports; Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Echocardiography (Mount Kisco, N.Y.)     Volume:  17     ISSN:  0742-2822     ISO Abbreviation:  Echocardiography     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-11-30     Completed Date:  2000-11-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8511187     Medline TA:  Echocardiography     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S17-23     Citation Subset:  IM    
CNR, Clinical Physiology Institute, Via Savi, 8, 56126 Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Contrast Media*
Coronary Disease / radionuclide imaging,  therapy*,  ultrasonography*
Echocardiography, Doppler, Color*
Image Enhancement / methods
Middle Aged
Sensitivity and Specificity
Sulfur Hexafluoride / diagnostic use*
Tomography, Emission-Computed, Single-Photon
Reg. No./Substance:
0/Contrast Media; 2551-62-4/Sulfur Hexafluoride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Design of an ultrasound contrast agent for myocardial perfusion.
Next Document:  Myocardial contrast echocardiography: clinical benefit and practical issues.